Redhill Biopharma Ltd. (RDHL)

RedHill Biopharma received a Nasdaq Staff Determination letter indicating non-compliance with minimum stockholders' equity requirements. The company plans to appeal the determination and believes its recent transaction with Cumberland Pharmaceuticals has improved its equity position.

Understand how market trends impact penny stocks The post The Impact of Market Trends on Penny Stocks Performance  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

RedHill Biopharma (RDHL) receives a new patent from the United States Patent and Trademark Office for its investigational COVID-19 candidate, opaganib, in COVID-19 patients with pneumonia. Stock up.

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talk will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.